How Cardiologs' AI uses Holter recordings to predict more AFib cases

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES Cardiologs is using Holter recordings instead of ECGs to catch more cases of AFib Cardiologs is developing a new model to predict atrial fibrillation. A new study, sponsored by the Paris-based company, showed that the algorithm can accurately predict the near-term presence or absence of AFib using only the first 24 hours of a Holter device recording. Sponsored Content BrightInsight launches new digital disease management solution for biopharma and medtech From BrightInsight and MedCity News BrightInsight developed the Disease Management Solution to help biopharma and medtech companies bring their Software as a Medical Device (SaMD)  to market faster, according to BrightInsight CEO and Co-founder Dr. Kal Patel. 1 Day of High-Quality, In-Person Meetings Around Digital Health Technology From MedCity News Join us in Dallas for MedCity INVEST Digital Health on Wednesday, September 28.  Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate. Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion By Frank Vinluan Tuesday, June 21, 2022 5:28 PM Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer. Read more » Here's how PeerCapsule is building a collaboration platform to jumpstart medical research By Katie Adams Tuesday, June 21, 2022 2:27 PM PeerCapsule, a Phoenix-based company developing a collaboration platform for professional healthcare associations, recently received funding from AWS' accelerator for early-stage startups led by founders from underrepresented groups. The startup will use the money to scale its platform and help build tools to enable faster clinical research. Read more » Aiming to catch Alnylam, AstraZeneca & Ionis plan FDA filing for rare disease drug By Frank Vinluan Tuesday, June 21, 2022 12:56 PM The planned FDA submission follows the report from AstraZeneca and Ionis Pharmaceuticals that their partnered drug, eplontersen, met the main goals of a pivotal study in treating nerve pain caused by hereditary transthyretin-mediated amyloidosis. The data come one week after rival Alnylam Pharmaceuticals won FDA approval for its second drug for this rare disease. Read more » Re-Defining Healthcare Recruitment with Deep Learning Automation Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively. Download this FREE eBook to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails